Pursuant to the Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parabolic Drugs has informed that a meeting of the Board of Directors of the company is scheduled to be held on Monday, the 29th day of May, 2017, to consider and approve the Audited Financial Results for the Year ended on 31st March, 2017. Pursuant to this, the Company has decided that the close period (i.e. closure of trading window) under the Company’s code of conduct for prevention of Insider Trading would commence from May 18, 2017 and end 24 hours after the results are made public on May 29, 2017.
The above information is a part of company’s filings submitted to BSE.
